β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices

Journal of Neuroscience

Volumn 16, Issue 3, 1996, Pages 1034-1040

  Kar, Satyabrata ^a   Seto, David ^a,b   Gaudreau, Pierrette ^c   Quirion, Remi ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

acetylcholine; Alzheimer's disease; hippocampus; neuromodulation; transmitter release; amyloid

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; DEGENERATIVE DISEASE; HIPPOCAMPUS; MALE; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029996479     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-03-01034.1996     Document Type: Article

References (56)

1. Abe E, Casamenti F, Giovannelli L, Scali C, Pepeu G (1994) Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res 636:162-164.
2. Araujo DM, Lapchak PA, Collier B, Chabot J-G, Quirion R (1989) Insulin-like growth factor-I (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res 484:130-138.
3. Araujo DM, Lapchak PA, Collier B, Quirion R (1990) Evidence that somatostatin enhances endogenous acetylcholine release in the hippocampus. J Neurochem 55:1546-1555.
4. Beeson JG, Shelton ER, Chan HW, Gage FH (1994) Differential distribution of amyloid protein precursor immunoreactivity in the rat brain studied by using five different antibodies. J Comp Neurol 342:78-96.
5. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 89:10075-10078.
6. Cai NS, Kiss B, Erdo SL (1991) Heterogeneity of N-methyl-D-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices. J Neurochem 57:2148-2151.
7. Chauhan A, Chauhan VPS, Brockerhoff H, Wisniewski HM (1993) Effect of amyloid beta-protein on membrane properties. In: Alzheimer's disease: advances in clinical and basic research (Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P, eds), pp 431-439. London: Wiley-Interscience.
8. Cordell B (1994) β-Amyloid formation as a potential therapeutic target for Alzheimer's disease. Ann Rev Pharmacol Toxicol 34:69-89.
9. Cotman CW, Pike CJ (1994) β-Amyloid and its contributions to neurodegeneration in Alzheimer disease. In: Alzheimer disease (Terry RD, Katzman R, Bick KL, eds), pp 305-315. New York: Raven.
10. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1124.
11. + channels. Science 264:276-278.
12. Etcheberrigaray R, Ito E, Oka K, Tofel-Grehl B, Gibson GE, Alkon DL (1993) Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer's disease. Proc Natl Acad Sci USA 90:8209-8213.
13. Flood JF, Morley JE, Roberts E (1991) Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease. Proc Natl Acad Sci USA 88:3363-3366.
14. Flood JF, Morley JE, Roberts E (1994) An amyloid β-protein fragment, Aβ[12-28], equipotently impairs post-training memory processing when injected into different limbic system structures. Brain Res 663:271-276.
15. Frey P, Lis M, Ristig D, Stauss U, Amstutz R, Swoboda R, Staufenbiel M (1994) Studies on the mechanism of β/A4 toxicity. Neurobiol Aging [Suppl] 15:518.
16. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seuhert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
17. Geula C, Mesulam MM (1994) Cholinergic systems and related neuropathological predilection patterns in Alzheimers disease. In: Alzheimer's disease (Terry RD, Katzman R, Bick KL, eds). pp 263-291. New York: Raven.
18. Giovannelli L, Casamenti F, Scali C, Bartolini L, Pepeu G (1995) Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 66:781-792.
19. Goldberg AM, McCaman RE (1973) The determination of picomole amounts of acetylcholine in mammalian brain. J Neurochem 20:1-8.
20. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325.
21. Hanisch UK, Seto D, Quirion R (1993) Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J Neurosci 13:3368-3374.
22. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12:383-388.
23. Hille B (1992) Ionic channels of excitable membranes, 2nd Ed. Sunderland, MA: Sinauer.
24. Hohmann C, Antuono P, Coyle JT (1988) Basal forebrain cholinergic neurones and Alzheimer's disease. In: Handbook of psychopharmacology: psychopharmacology of the aging nervous system (Iversen LL, Snyder SH, eds), pp 69-106. New York: Plenum.
25. Iverfeldt K, Walaas SI, Greengard P (1993) Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. Proc Natl Acad Sci USA 90:4146-4150.
26. Joslin G, Krause JE, Hershey AD, Adams SP, Fallon RJ, Perlmutter DH (1991) Amyloid-β peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. J Biol Chem 266:21897-21902.
27. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325:733-736.
28. Kim CS, Han YF, Etcheberrigaray R, Nelson TJ, Olds JL, Yoshioka T, Alkon DL (1995) Alzheimer and β-amyloid treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20. Proc Natl Acad Sci USA 92:3060-3064.
29. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Gilbert J (1995) The Alzheimer Aβ peptide induces neurodegeneration and apoptic cell death in transgenic mice. Nature Genetics 9:21-30.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1952) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
31. Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW (1992) Reversible in vitro growth of Alzheimer's disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89:5462-5466.
32. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 16:409-414.
33. Mitsuhashi M, Akitaya T, Turk CW, Payan DG (1991) Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cells. Mol Brain Res 11:177-180.
34. Mullan M, Crawford F (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci 16:398-403.
35. Narahashi T (1974) Chemicals as tools in the study of excitable membranes. Physiol Rev 54:813-889.
36. Nishimoto I, Okamoto T, Matsuura Y, Takahashi S, Okamoto T, Murayama Y, Ogata E (1993) Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go. Nature 362:75-79.
37. Nitsch RM, Growdon JH (1994) Role of neurotransmission in the regulation of amyloid β-protein precursor processing. Biochem Pharmacol 47:1275-1284.
38. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304-307.
39. Okamoto T, Takeda S, Murayama Y, Ogata E, Nishimoto I (1995) Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J Biol Chem 270:4205-4208.
40. Ouimet CC, Baerwald KD, Gandy SE, Greengard P (1994) Immunocytochemical localization of amyloid precursor protein in the rat brain. J Comp Neurol 348:244-260.
41. Pearce LB, Buck T, Adamec E (1991) Rapid kinetics of potassium-evoked release of acetylcholine from rat brain synaptosomes: analysis by rapid superfusion. J Neurochem 57:636-647.
42. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
43. Price D (1986) New perspectives on Alzheimer's disease. Annu Rev Neurosci 9:489-512.
44. Quirion R (1993) Cholinergic markers in Alzheimer's disease and the autoregulation of acetylcholine release. J Psychiatry Neurosci 18:226-234.
45. Roberts E (1986) Guides through the labyrinth of AD: dehydroepiandrosterone, potassium channels and the C4 component of complement. In: Treatment development strategies for Alzheimer's disease (Crook T, Bartus RT, Ferris S, Gershon S, eds), pp 173-219. New Haven, CT: Powley.
46. Rodriguez de lores Arnaiz G (1988) Molecular aspects of acetylcholine release: an overview. Prog Brain Res 98:213-218.
47. Selkoe D (1993) Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci 16:403-409.
48. Selkoe D (1994) Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17:489-517.
49. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer β-peptide from biological fluids. Nature 359:325-327.
50. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai XD, Makay DM, Tintner R, Frangione B, Younkin SG (1992) Production of Alzheimer β protein by normal proteolytic processing. Science 258:126-129.
51. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248:492-495.
52. St George-Hyslop P (1994) The molecular genetics of Alzheimer's disease. In: Alzheimer's disease (Terry RD, Katzman R, Bick KL, eds), pp 345-352. New York: Raven.
53. Strittmatter WJ, Huang DY, Bhasin R, Roses AD, Goldgaber D (1993) Avid binding of β amyloid peptide to its own precursor. Exp Neurol 122:327-334.
54. Wallace W, Ahlers ST, Gotlib J, Bragin V, Sugar J, Gluck R, Shea PA, Davis KL, Haroutunian V (1993) Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc Natl Acad Sci USA 90:8712-8716.
55. Wurtman RJ (1992) Choline metabolism as a basis for the selective vulnerability of cholinergic neurones. Trends Neurosci 15:117-122.
56. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-282.